Cargando…
Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease
BACKGROUND: Chronic administration of levodopa in Parkinson’s disease leads to debilitating involuntary movements, termed levodopa-induced dyskinesia (LID). The pathogenesis of LID is poorly understood. Previous research has shown that histamine H(2) receptors are highly expressed in the input (stri...
Autores principales: | Cui, Guiyun, Yang, Xinxin, Wang, Xiaoying, Zhang, Zunsheng, Yue, Xuanye, Shi, Hongjuan, Shen, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872142/ https://www.ncbi.nlm.nih.gov/pubmed/24379672 http://dx.doi.org/10.2147/NDT.S54782 |
Ejemplares similares
-
Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats
por: Shi, Hongjuan, et al.
Publicado: (2015) -
“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016) -
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
por: Zheng, Chang-Qing, et al.
Publicado: (2021) -
Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s disease
por: Yang, Xinxin, et al.
Publicado: (2013) -
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)